Page last updated: 2024-10-20

pyridoxamine and Acute Confusional Senile Dementia

pyridoxamine has been researched along with Acute Confusional Senile Dementia in 2 studies

Research Excerpts

ExcerptRelevanceReference
"At present there is no therapy for Alzheimer's Disease which completely stops the progressive dementia effecting late onset Alzheimer's Disease (AD) patients."1.46A unique and promising combination of medications for the treatment of Alzheimer's disease. ( Weinstein, JD, 2017)
"Cu(II) complexes of Alzheimer's disease-related β-amyloid (Aβ) peptides exhibit metal-centered oxidation chemistry."1.37Vitamin B6s inhibit oxidative stress caused by Alzheimer's disease-related Cu(II)-β-amyloid complexes-cooperative action of phospho-moiety. ( Hashim, A; Juneja, K; Ming, LJ; Wang, L; Ye, Y; Zhao, Y, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashim, A1
Wang, L1
Juneja, K1
Ye, Y1
Zhao, Y1
Ming, LJ1
Weinstein, JD1

Other Studies

2 other studies available for pyridoxamine and Acute Confusional Senile Dementia

ArticleYear
Vitamin B6s inhibit oxidative stress caused by Alzheimer's disease-related Cu(II)-β-amyloid complexes-cooperative action of phospho-moiety.
    Bioorganic & medicinal chemistry letters, 2011, Nov-01, Volume: 21, Issue:21

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Humans; Oxidative Stress; Reactive Oxygen Species;

2011
A unique and promising combination of medications for the treatment of Alzheimer's disease.
    Medical hypotheses, 2017, Volume: 109

    Topics: Alzheimer Disease; Brain; Dementia; Disease Progression; Drug Design; Drug Therapy, Combination; Hum

2017